The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of regorafenib therapy on health-related quality of life (HRQoL) in patients with metastatic colorectal cancer (mCRC) in the phase III CONCUR trial.
 
Shukui Qin
No Relationships to Disclose
 
Tae Won Kim
Consulting or Advisory Role - Abbvie; Merck
Research Funding - Bayer
 
Thomas Cheung Yau
Consulting or Advisory Role - Bayer
 
Brigette Ma
Honoraria - Merck Serono; Novartis
Consulting or Advisory Role - Boehringer Ingelheim; Novartis
Research Funding - Novartis; Roche; Sanofi
 
Hongming Pan
No Relationships to Disclose
 
Jian-Ming Xu
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Liwei Wang
No Relationships to Disclose
 
Kun-Huei Yeh
No Relationships to Disclose
 
Feng Bi
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Tuan Anh Le
No Relationships to Disclose
 
Jen-Kou Lin
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Ma Dong
No Relationships to Disclose
 
Christian Kappeler
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Jane Chang
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Rui-hua Xu
No Relationships to Disclose
 
Jin Li
Consulting or Advisory Role - Pfizer; Roche
Research Funding - HenRui; Merck